FOXA2 and adenocarcinoma: Furthermore, results from research using the transgenic adenocarcinoma of the mouse prostate (TRAMP) mouse model indicate that FOXA2 functions together with HIF1α to drive a transcriptional program essential for NEPC development [15], thus establishing FOXA2 as a driving factor for NEPC.